Jasper Therapeutics, Inc. - Class A (JSPR) analyst actions

Rating and price-target actions on JSPR in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the JSPR overview →

3 measured JSPR analyst action events.

DateHeadlineEvent5-minTo close
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Jasper Therapeutics, Inc. (JSPR) And Encourages Stockholders to Reach OutPress release-1.40%-3.90%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Jasper Therapeutics, Inc. (JSPR) And Encourages Shareholders to Reach OutPress release+4.62%+1.73%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Jasper Therapeutics, Inc. (JSPR) And Encourages Stockholders to Reach OutPress release-1.08%+4.22%
Get an email when JSPR moves on news →
Keep exploring

More JSPR: earnings → · SEC filings → · JSPR overview →